M

Medicxi Ventures Management Ltd Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Medicxi Ventures Management Ltd with $744.4M in long positions as of Q3 2025, 65% allocated to Unknown, and 100% concentrated in top 10 positions.

Portfolio Value
$744.4M
Top 10 Concentration
100%
Top Sector
Unknown (65%)
US Exposure
89%
Market Cap Focus
N/A
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 35.00%Healthcare
Healthcare
35.00%

Industry Breakdown

1 industry across all sectors

Biotechnology: 34.97%Biotechnology
Biotechnology
Healthcare
34.97%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 10.96%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 24.01%Small Cap ($300M - $2B)N/A (ETF or Unknown): 65.03%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
10.96%
Small Cap ($300M - $2B)
24.01%
N/A (ETF or Unknown)
65.03%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
89.04%
International
10.96%
Countries
2
Largest Int'l Market
Netherlands - 10.96%
United States of America
89.04% ($662.8M)
4 holdings
Netherlands
10.96% ($81.6M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
12.6 quarters
Avg. Top 20
12.6 quarters
Avg. All Positions
12.6 quarters
Median Holding Period
11 quarters
Persistence Rate
80.0%
Persistent Holdings Weight
90.32%
Persistent Positions
4
Longest Held
Phathom Pharmaceuticals, Inc. Common Stock logo
Phathom Pharmaceuticals, Inc. Common StockPHAT - 23 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
20.00%
Largest Position
CNTA
Centessa Pharmaceuticals plc American Depositary SharesCNTA - 65.03%
Largest Ownership Stake
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 16.89%
Avg. Ownership Stake
3.28%
Ownership Stake >5%
2
Ownership Stake >1%
4

Historical (Since Q4 2019)

Avg. New Position
29.74%
Avg. Ownership Stake
3.91%
Largest Position
Phathom Pharmaceuticals, Inc. Common Stock logo
Phathom Pharmaceuticals, Inc. Common StockPHAT - 74.08% (Q4 2019)
Largest Ownership Stake
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 63.94% (Q4 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
4.8%
Value Traded
$36.03M
Positions Added
0
Positions Exited
0

Historical (Since Q4 2019)

Avg. Turnover Ratio
6.2%
Avg. Positions Added
0
Avg. Positions Exited
0
Highest Turnover
50.0%
Q4 2019

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.